Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma;Quimioembolización del hepatocarcinoma: partículas cargadas frente a quimioembolización convencional

Radiologia

Volumn 53, Issue 3, 2011, Pages 246-253

  Ferrer Puchol, M D ^a   La Parra, C ^a   Esteban, E ^a   Vano M ^a   Forment, M ^a   Vera, A ^a   Cosin O ^a  

^a HOSPITAL DE LA RIBERA   (Spain)

Author keywords

Carcinoma; Doxorubicin eluting beads; Hepatocellular carcinoma; Intra arterial chemoembolization; Liver; Treatment

Indexed keywords

DOXORUBICIN;

ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOXORUBICIN ELUTING BEAD TRANSARTERIAL CHEMOEMBOLIZATION; DRUG TOLERABILITY; HUMAN; LIVER CELL CARCINOMA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESPONSE EVALUATION CRITERIA ON SOLID TUMORS; SCORING SYSTEM; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; DRUG CARRIERS; HUMANS; LIVER NEOPLASMS; MICROSPHERES; PROSPECTIVE STUDIES;

EID: 79959517589     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/j.rx.2010.07.010     Document Type: Article

References (18)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the World cancer burden: Globocan 2000 Int J Cancer. 94 2001 153 156 (Pubitemid 32911406)
2. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology. 35 2002 519 524 (Pubitemid 34183954)
3. J.M. Llovet, and J. Bruix Systematic review of randomized trial for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology. 37 2003 429 442 (Pubitemid 36152543)
4. A. Forner, C. Ayuso, M.I. Real, J. Sastre, R. Robles, and B. Sangro Diagnóstico y tratamiento del carcinoma hepatocelular Med Clin (Barc). 132 2009 272 287
5. A.L. Lewis, R.R. Taylor, and B. Hall Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol. 17 2006 1335 1343 (Pubitemid 44259017)
6. M. Varela, M.I. Real, and M. Burrel Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol. 46 2007 474 481 (Pubitemid 46201723)
7. R. Lencioni, K. Malagari, T. Vogl, F. Pilleul, A. Denys, and A. Watkinson A randomized phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatherer arterial chemoembolization J Clin Oncol. 27 2009 4523
8. R. Dhanasekaran, D.A. Kooby, C.A. Staley, J.S. Kauh, and H.S. Kim Drug eluting beads versus conventional TACE for unresecable hepatocellular carcinoma: Survival benefits and safety J Clin Oncol. 27 2009 4524
9. K. Malagari, E. Alexopoulou, K. Chatzimichail, B. Hall, J Koskinas, and S. Ryan Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead Abdominal Imaging. 33 2008 512 519
10. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis. 19 1999 329 338
11. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the study of the Liver J Hepatol. 35 2001 421 430 (Pubitemid 32844200)
12. J. Collier, and M. Sherman Screening for hepatocellular Carcinoma Hepatology. 27 1998 273 279
13. J. Bruix, and M. Sheman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236 (Pubitemid 43112690)
14. M. Buijs, J.A. Vossen, C. Frangakis, K. Hong, C.S. Georgiades, and Y. Chen Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization. Single-Center Experience Radiology. 249 2008 346 354
15. J. Namur, M. Wassef, J.M. Millot, A.L. Lewis, M. Manfait, and A. Laurent Durug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model J Vasc Interv Radiol. 21 2010 259 267
16. J. Lammer, K. Malagari, T. Vogl, F. Pilleul, A. Denys, and A. Watkinson Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol. 33 2010 41 42
17. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, and R.T. Poon Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology. 35 2002 1164 1171 (Pubitemid 34454013)
18. J.M. Llovet, I. Real, X. Montaña, R. Planas, S. Coll, and J. Aponre Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. A randomized controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)